NDC 13668-453
anagrelide
Anagrelide
anagrelide is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is Anagrelide Hydrochloride.
Product ID | 13668-453_8a2d4098-44e4-4eff-96b6-336cf7081c81 |
NDC | 13668-453 |
Product Type | Human Prescription Drug |
Proprietary Name | anagrelide |
Generic Name | Anagrelide |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2017-06-30 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA209151 |
Labeler Name | Torrent Pharmaceuticals Limited |
Substance Name | ANAGRELIDE HYDROCHLORIDE |
Active Ingredient Strength | 1 mg/1 |
Pharm Classes | Decreased Platelet Production [PE],Platelet-reducing Agent [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |